Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates

Go back to Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates
(NASDAQ: VRDN) Delayed: 22.37 -0.45 (1.97%)
Previous Close $22.82    52 Week High $ 
Open $22.75    52 Week Low $ 
Day High $22.75    P/E N/A 
Day Low $21.92    EPS $ 
Volume 1,175,809